Experienced in Chronic B-Cell Leukemia (CBCL)

Miriam Ladicka

Bratislava, BL, SK 
Experienced in Chronic B-Cell Leukemia (CBCL)
Bratislava, BL, SK 
OverviewLocationsClinical Research

Overview

Miriam Ladicka practices in Bratislava, Slovakia. Ms. Ladicka is rated as an Experienced expert by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). Her top areas of expertise are Progressive Multifocal Leukoencephalopathy, Small Lymphocytic Lymphoma (SLL), Chronic Lymphocytic Leukemia (CLL), and Chronic B-Cell Leukemia (CBCL).

Her clinical research consists of co-authoring 9 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Chronic B-Cell Leukemia (CBCL).

Gender
Female

Locations

Bratislava, BL, Slovakia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Controlled, Open-Label Phase 3 Study of Melflufen in Combination With Daratumumab Compared With Daratumumab in Patients With Relapsed or Relapsed-Refractory Multiple Myeloma
A Randomized, Controlled, Open-Label Phase 3 Study of Melflufen in Combination With Daratumumab Compared With Daratumumab in Patients With Relapsed or Relapsed-Refractory Multiple Myeloma
Enrollment Status: Terminated
Publish Date: June 08, 2023
Intervention Type: Drug
Study Drugs: Melphalan Flufenamide, Dexamethasone, Daratumumab
Study Phase: Phase 3

9 Total Publications

Factors influencing survival after allogeneic stem cell transplantation for hematologic malignancies in adult patients: A retrospective cohort study.
Factors influencing survival after allogeneic stem cell transplantation for hematologic malignancies in adult patients: A retrospective cohort study.
Journal: Neoplasma
Published: March 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Ladicka's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile